NuVasive launches latest porous PEEK implant for posterior spine surgery

472

NuvasiveNuVasive has announced the launch of its Cohere TLIF-O implant as well as the upcoming launch later this year of the Cohere TLIF-A implant. These two additions mean that it is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery, say NuVasive.

Cohere TLIF-O is a porous PEEK implant for the transforaminal lumbar interbody fusion (TLIF) procedure with a variety of implant sizes to accommodate various patient anatomies and procedurally designed instrumentation.

Massimo Calafiore, chief commercial officer of NuVasive, said: “NuVasive is focused on providing a comprehensive spine offering across all procedural segments to address some of the most challenging aspects of spine surgery. Porous PEEK is a clear differentiator for us in the market, and the launch of Cohere TLIF-O and future addition of Cohere TLIF-A furthers our commitment to this one-of-a-kind technology.

“The company has a uniquely differentiated TLIF portfolio to support the most widely used posterior spine procedure and we will continue to invest in outcome-driven innovation that drives the greatest impact for our surgeons, providers, and patients.”

Later in the fourth quarter, the company plans to launch the Cohere TLIF-A implant. While the device has similar clinical properties to Cohere TLIF-O, the Cohere TLIF-A implant is designed for anterior column support to maximise sagittal alignment correction.

Frank Phillips, MD, professor of orthopaedic surgery and director of the Division of Spine Surgery at Rush University Medical Centre in Chicago, USA, added: “Porous PEEK combines the stiffness and radiolucency of PEEK with the enhanced osseo-integration of the porous technology—benefits not possible with prior devices.

“The enhanced clinical outcomes possible with Cohere TLIF-O and the comprehensive surface technology options for posterior spine surgery now available are helping advance the standard of patient care.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here